James Bogenberger
Therapeutics Team Lead at LongeVC
About
James Bogenberger is a translational precision oncology researcher whose therapeutics development experience spans functional genomics target identification through clinical correlative studies, including preclinical and clinical work on small molecule, biologic, viral oncolytic, and gene therapy approaches. He previously held roles as an American Cancer Society Postdoctoral Fellow and as a Research Associate and Assistant Professor of Medicine and Molecular Medicine at Mayo Clinic. Since 2020 he has served as CSO at Statum Capital Partners' multi-family office.
Invests in
BiotechLongevity
Colleagues at LongeVC
Alex Zhavoronkov
Venture Partner at LongeVC
Artem Trotsyuk
Operating Partner - US at LongeVC
Artemy Shumskiy
Principal at LongeVC
Christine Yuan Huang
Advisory Board at LongeVC
Dr. Weigao Wang
Venture Fellow at LongeVC
Evelyne Bischof
Venture Partner at LongeVC
Evgeny Izumchenko
Venture Partner at LongeVC
Garri Zmudze
Managing Partner at LongeVC